US$ 22.26
glp 1 agonists muscle loss with GLP-1 Medications: What You Need to Know | Internal Medicine & Primary Care located in Clifton and Maywood, NJ GLP-1 Genetics: How Genes Affect
Description
2019;29:320334.e5

None of the above-mentioned companies had any role in the preparation of this paper, which has been written independently and without any financial or professional help

GLP-1 receptor agonists do not increase the risk of hypoglycemia relative to placebo (48)

Curr Epidemiol Rep

This increasing diabetic population drives the demand for insulin and GLP-1 receptor agonists in the region
The recommendation is based on a trial comparing semaglutide with placebo in people with overweight/obesity with CVD but no diabetes (Lincoff et al, 2023)
